Form 990 for tax year 2024
Filed by NEURODEGENERATIVE DISEASE RESEARCH INC.
Totals
- Total revenue
- $1,561,118
- Total expenses
- $1,540,222
- Contributions and grants received
- $1,561,118
- Grants paid
- $742,929
- Program service revenue
- $0
- Investment income
- $0
- Other revenue
- $0
- Total assets, end of year
- $248,396
- Total liabilities, end of year
- $161
- Net assets or fund balances, end of year
- $248,235
- Program services expenses (Part IX)
- $1,511,994
- Management and general expenses
- $24,735
- Fundraising expenses
- $3,493
- Program service expenses (Part III)
- $1,511,994
Program services were 98.2% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.
Line items
Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.
Revenue
Part VIII, the statement of revenue.
-
1f · All other contributions, gifts and grants
$1,561,118
-
8c · Net income from fundraising events
total $0
Functional expenses
Part IX, the statement of functional expenses.
-
1 · Grants to domestic organizations and governments
total $615,818 · program services $615,818
-
3 · Grants to foreign organizations and individuals
total $127,111 · program services $127,111
-
5 · Compensation of officers, directors and key employees
total $150,000 · program services $135,000 · management and general $12,000 · fundraising $3,000
-
10 · Payroll taxes
total $11,487 · program services $10,338 · management and general $919 · fundraising $230
-
11b · Fees: legal
total $20,600 · program services $20,600
-
11c · Fees: accounting
total $3,571 · management and general $3,571
-
11g · Fees: other
total $143,855 · program services $136,662 · management and general $7,193
-
13 · Office expenses
total $13,148 · program services $11,833 · management and general $1,052 · fundraising $263
-
24a · Other expenses: Drug Manufacturing Exp
total $454,632 · program services $454,632
Balance sheet
Part X, book values.
-
1 · Cash, non-interest-bearing
beginning of year $68,681 · end of year $89,552
-
10a · Land, buildings and equipment: cost or other basis
$158,844
-
10c · Land, buildings and equipment, net
beginning of year $158,844 · end of year $158,844
-
17 · Accounts payable and accrued expenses
beginning of year $186 · end of year $161
-
27 · Net assets without donor restrictions
beginning of year $227,339 · end of year $248,235
Mission and programs · 2024
Mission
Our goal is to facilitate research that will bring new treatments to those suffering from neurodegenerative diseases. We fund researchers that have projects intended to bring new hope to ALS patients.
-
Our mission is to fund researchers with an emphasis to identify and validate biomarkers for determining drug effectiveness in neurodegenerative diseases and facilitate pathology-based treatments to ALS patients.
Expenses $1,511,994 · Grants $742,929
As filed on the 2024 return.
Listed in Part VII
-
Siobhan Ellison
President and CEO
- Total calculated
- $150,000
- From this org
- $150,000
- From related orgs
- $0
- Other
- $0
- Hours/week
- 40
-
Julie Osborne
Board Member
- Total calculated
- $0
- Hours/week
- 6
-
Bill Killeen
Vice President
- Total calculated
- $0
- Hours/week
- 6
Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.
Grants on this return
-
Rho Worldwide Inc
$609,817
Medical research
-
Medical research
Provenance
- Return type
- form_990
- Tax year
- 2024
- Filed
- 11 June 2025
- IRS schema version
- 2024v5.1
- Source object
- 202511819349300421
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.